Waystar (WAY) vs. The Competition Head to Head Analysis

Waystar (NASDAQ:WAY – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it weigh in compared to its rivals? We will compare Waystar to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Valuation & Earnings

This table compares Waystar and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Waystar $1.10 billion $112.09 million 41.09
Waystar Competitors $342.08 million -$24.15 million 12.97

Waystar has higher revenue and earnings than its rivals. Waystar is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Waystar and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waystar 0 4 17 2 2.91
Waystar Competitors 451 1531 2741 89 2.51

Waystar presently has a consensus price target of $35.23, indicating a potential upside of 24.26%. As a group, “Healthcare Technology” companies have a potential upside of 44.97%. Given Waystar’s rivals higher probable upside, analysts clearly believe Waystar has less favorable growth aspects than its rivals.

Profitability

This table compares Waystar and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Waystar 10.70% 6.95% 4.69%
Waystar Competitors -778.93% -33.97% -15.65%

Insider & Institutional Ownership

42.2% of shares of all “Healthcare Technology” companies are owned by institutional investors. 3.5% of Waystar shares are owned by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk & Volatility

Waystar has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, Waystar’s rivals have a beta of 1.13, indicating that their average share price is 13% more volatile than the S&P 500.

Summary

Waystar beats its rivals on 9 of the 13 factors compared.

About Waystar

(Get Free Report)

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.

Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.